Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Prendergast

Showing results (51-60 of 247) with videos related to

Pageof 25
Sort By:
American Journal of Perinatology|January 30, 2007
Barriers to provision of developmental care in the neonatal intensive care unit: neonatal nursing perceptionsKaren D Hendricks-Muñoz, Carol C Prendergast
Plos One|November 2, 2022
Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatmentSunil Thomas, Giancarlo Mercogliano, George C Prendergast
Cancer Research|September 15, 1999
Activation of the PI3'K-AKT pathway masks the proapoptotic effects of farnesyltransferase inhibitorsW Du, A Liu, G C Prendergast
Oncogene|October 26, 2005
RhoB facilitates c-Myc turnover by supporting efficient nuclear accumulation of GSK-3M Huang, U Kamasani, G C Prendergast
The Journal of Biological Chemistry|June 27, 1997
Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcriptionP F Lebowitz, W Du, G C Prendergast
Methods in Enzymology|November 16, 2019
Reliable detection of indoleamine 2,3 dioxygenase-1 in murine cells and tissuesSunil Thomas, Lisa Laury-Kleintop, George C Prendergast
Cell Cycle (Georgetown, Tex.)|May 28, 2009
IDO recruits Tregs in melanomaGeorge C Prendergast, Richard Metz, Alexander J Muller
Cancer Research|January 26, 2002
Farnesyltransferase inhibitors reverse Ras-mediated inhibition of Fas gene expressionBin Zhang, George C Prendergast, Robert G Fenton
Cancer Research|May 8, 1999
Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitorsW Du, P F Lebowitz, G C Prendergast
Cancer Journal (Sudbury, Mass.)|January 24, 2023
A Brief Overview of Cancer VaccinesAlexander J Muller, Sunil Thomas, George C Prendergast
Pageof 25

Showing results (51-60 of 247) with videos related to

Sort By:
Pageof 25
American Journal of Perinatology|January 30, 2007
Barriers to provision of developmental care in the neonatal intensive care unit: neonatal nursing perceptionsKaren D Hendricks-Muñoz, Carol C Prendergast
Plos One|November 2, 2022
Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatmentSunil Thomas, Giancarlo Mercogliano, George C Prendergast
Cancer Research|September 15, 1999
Activation of the PI3'K-AKT pathway masks the proapoptotic effects of farnesyltransferase inhibitorsW Du, A Liu, G C Prendergast
Oncogene|October 26, 2005
RhoB facilitates c-Myc turnover by supporting efficient nuclear accumulation of GSK-3M Huang, U Kamasani, G C Prendergast
The Journal of Biological Chemistry|June 27, 1997
Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcriptionP F Lebowitz, W Du, G C Prendergast
Methods in Enzymology|November 16, 2019
Reliable detection of indoleamine 2,3 dioxygenase-1 in murine cells and tissuesSunil Thomas, Lisa Laury-Kleintop, George C Prendergast
Cell Cycle (Georgetown, Tex.)|May 28, 2009
IDO recruits Tregs in melanomaGeorge C Prendergast, Richard Metz, Alexander J Muller
Cancer Research|January 26, 2002
Farnesyltransferase inhibitors reverse Ras-mediated inhibition of Fas gene expressionBin Zhang, George C Prendergast, Robert G Fenton
Cancer Research|May 8, 1999
Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitorsW Du, P F Lebowitz, G C Prendergast
Cancer Journal (Sudbury, Mass.)|January 24, 2023
A Brief Overview of Cancer VaccinesAlexander J Muller, Sunil Thomas, George C Prendergast
Pageof 25